Pharmaceutical manufacturer expands facility to increase production

Veterinary pharmaceuticals manufacturer Pegasus Laboratories, a subsidiary of PBI-Gordon Companies, celebrated the grand opening of its expanded facility in Pensacola, Florida, with a ribbon cutting ceremony on September 18, 2025. This expansion is a critical step in Pegasus Laboratories’ continued growth and commitment to improving animal health across the nation, according to the company.

Photo: Daniel/Adobe Stock

The new facility, spanning 172,000 square feet, consists of 3 building phases that will increase manufacturing capacity, provide state-of-the-art laboratory spaces, and enhance the company’s ability to produce high-quality veterinary products for pets. The expansion was assisted by the FloridaWest Economic Development Alliance in securing a $2.5 million grant from Triumph Gulf Coast to the Pensacola–Escambia Promotion and Development Commission (PEDC) for the acquisition of the facility. FloridaWest served as the local economic development partner helping to advance the project, while Triumph Gulf Coast’s investment is part of its broader initiative to stimulate economic growth in the region through support for projects that create high-paying jobs and foster innovation.

“The funding of this renovated facility is an example of how targeted public investment can drive meaningful economic impact,” David Bear, President of the FloridaWest board of directors, said in a news release. “We are thrilled to see Pegasus Laboratories continue to grow in Pensacola, creating valuable, high-skilled jobs in the life sciences sector.”

Pegasus Laboratories is advancing its expansion with the creation of nearly 70 new jobs, including highly skilled positions across manufacturing, quality control, research and development, and management. Thus far, the company has invested more than $7 million in capital expenditures toward the project, with additional build-out phases anticipated to require up to $45 million to bring the full development to completion.

“By expanding our operations in Pensacola, we’re not just increasing our production capacity, but we’re also investing in the future of our employees and the communities we serve,” Steve Clifford, CEO of Pegasus Laboratories, said in a news release. “Our growth here is a direct result of the support from the FloridaWest Economic Development Alliance, Triumph Gulf Coast, and local economic development partners who understand the importance of sustainable, high-tech jobs.”

Pegasus Laboratories products are used by veterinarians across the country to treat a range of chronic conditions in pets. The new facility will enhance the company’s ability to meet growing demands for its high-quality products while adhering to the highest standards of manufacturing and animal health safety, according to the company.

RELATED: Novel cardiology therapy for cats in launched.

Reference

Pegasus Laboratories unveils new Pensacola facility, bringing jobs, innovation and growth to community. News release. September 18, 2025.